Published in

Institute for Operations Research and Management Sciences, INFORMS Journal on Computing, 2021

DOI: 10.1287/ijoc.2020.1009

Links

Tools

Export citation

Search in Google Scholar

Ranking and Selection with Covariates for Personalized Decision Making

Journal article published in 2021 by Haihui Shen ORCID, L. Jeff Hong ORCID, Xiaowei Zhang ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We consider a problem of ranking and selection via simulation in the context of personalized decision making, in which the best alternative is not universal, but varies as a function of some observable covariates. The goal of ranking and selection with covariates (R&S-C) is to use simulation samples to obtain a selection policy that specifies the best alternative with a certain statistical guarantee for subsequent individuals upon observing their covariates. A linear model is proposed to capture the relationship between the mean performance of an alternative and the covariates. Under the indifference-zone formulation, we develop two-stage procedures for both homoscedastic and heteroscedastic simulation errors, respectively, and prove their statistical validity in terms of average probability of correct selection. We also generalize the well-known slippage configuration and prove that the generalized slippage configuration is the least favorable configuration for our procedures. Extensive numerical experiments are conducted to investigate the performance of the proposed procedures, the experimental design issue, and the robustness to the linearity assumption. Finally, we demonstrate the usefulness of R&S-C via a case study of selecting the best treatment regimen in the prevention of esophageal cancer. We find that by leveraging disease-related personal information, R&S-C can substantially improve patients’ expected quality-adjusted life years by providing a patient-specific treatment regimen.